前列腺癌基因核酸放大檢測系統
PMA 核准號：P100033 · 2020-07-21
廣告
器材摘要
Prostrate cancer genes nucleic acid amplification test system is the device name listed in this FDA 510(k) record. The listed applicant is Gen-Probe Incorporated. It received FDA 510(k) clearance on 2020-07-21. The device is classified under product code OYM. It was reviewed by the PA advisory panel.
常見問題
What is the Prostrate cancer genes nucleic acid amplification test system?
Prostrate cancer genes nucleic acid amplification test system is a medical device that received FDA 510(k) clearance on 2020-07-21. The listed applicant is Gen-Probe Incorporated.
When did Prostrate cancer genes nucleic acid amplification test system receive FDA 510(k) clearance?
The clearance date for Prostrate cancer genes nucleic acid amplification test system can be found in the official FDA records.
Who is the listed applicant for Prostrate cancer genes nucleic acid amplification test system?
The FDA 510(k) record lists Gen-Probe Incorporated as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for Prostrate cancer genes nucleic acid amplification test system?
The FDA product code for Prostrate cancer genes nucleic acid amplification test system is OYM.
相關臨床試驗
相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係，請查閱連結的官方來源。
官方來源
在 FDA 資料庫中查看 →資料來源為 FDA Open API。如需最新且權威的資訊，請始終參閱官方記錄。
廣告